Cargando…
Rate control with calcium channel blockers versus betablockers in patients with paroxysmal and persistent atrial fibrillation - data from the AFFIRM trial
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. PURPOSE: To investigate whether there are differences between nondihydropyridine calcium channel blockers and beta blockers on heart rate in patients with paroxysmal and persistent atrial fibrillation (AF). METHODS: In present analysis of the...
Autores principales: | Koldenhof, T, Van Gelder, I C, Crijns, H J G M, Rienstra, M, Tieleman, R G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207001/ http://dx.doi.org/10.1093/europace/euad122.073 |
Ejemplares similares
-
Personalized rate control treatment for atrial fibrillation: a prospective case-control study on the use of diltiazem
por: Spadotto, A, et al.
Publicado: (2023) -
Mid-term follow-up of atrioventricular node ablation and conduction system pacing without a ventricular backup lead in atrial fibrillation-induced tachycardiomyopathy - a single-center experience
por: Pestrea, C G, et al.
Publicado: (2023) -
Incidence of conversion to sinus rhythm in refractory atrial fibrillation patients after atrioventricular node ablation with conduction system pacing
por: Ivanovski, M, et al.
Publicado: (2023) -
His bundle pacing and AV nodal ablation for non-controlled atrial arrhythmia: a technical challenge with major clinical benefits
por: Chaumont, C, et al.
Publicado: (2023) -
Number of comorbidities is associated with symptom severity and arrhythmia progression in paroxysmal atrial fibrillation - Data from the RACE V study
por: Van De Lande, M E, et al.
Publicado: (2023)